Opioid detox for Highland Beach — fentanyl-era protocols, buprenorphine done right.

Twelve minutes down A1A from Bel Lido Isle or Toscana, RECO Island runs a small-census, physician-led opioid detox built for the fentanyl era — COWS-guided buprenorphine induction, low-dose protocols when indicated, and comfort medications layered from admission rather than withheld until symptoms peak. Detox and residential treatment share one campus, so stabilization moves directly into structured care without a discharge-and-readmit gap. Every client leaves with an active MAT plan, a confirmed outpatient prescriber, a first appointment on the calendar, and intranasal naloxone in hand.

Highland Beach occupies a narrow oceanfront corridor between Delray Beach and Boca Raton — roughly three miles of A1A, a cluster of gated enclaves, and about twelve minutes by car to RECO Island’s Delray campus. For residents of Bel Lido Isle, Toscana, Ocean Cove, or Boca Cove weighing opioid detox, that geography matters: direct admission to a small-census, physician-led detox unit without an emergency-department detour or a third-party handoff after stabilization. What competent opioid detox looks like in 2026 — fentanyl-dominated supply, unpredictable adulterants, elevated precipitated-withdrawal risk — is not what it looked like a decade ago, and program selection should reflect that.

Opioid withdrawal in the fentanyl era

Fentanyl and its analogs have materially changed the clinical picture of opioid withdrawal. The drug’s high lipophilicity means it sequesters in adipose tissue and washes out unpredictably; the peripheral half-life estimates that once informed induction timing no longer describe what patients experience. Withdrawal emerges faster in some cases and lingers longer in others, and adulterants — xylazine most prominently — layer a non-opioid withdrawal syndrome on top of the opioid one, complicating symptom assessment and comfort-medication selection.

The practical consequence: the pre-fentanyl buprenorphine induction playbook — wait 12 to 24 hours, dose at moderate withdrawal — precipitates severe withdrawal in a meaningful subset of fentanyl-exposed patients. RECO Island’s protocol treats every admission as a fentanyl-exposed case until history and urine toxicology say otherwise, defaulting to extended observation and, when indicated, low-dose or micro-induction sequences rather than standard rapid induction. That is not the more conservative choice; it is the current standard of care in addiction medicine.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale (COWS) scores eleven domains — pulse rate, sweating, restlessness, pupil size, bone and joint aches, rhinorrhea and lacrimation, gastrointestinal upset, tremor, yawning, anxiety and irritability, and gooseflesh skin — stratifying withdrawal as mild, moderate, moderately severe, or severe. Nursing repeats COWS every two to four hours during the induction window, and physician decisions about first-dose timing key off both the numeric score and the clinical narrative behind it.

For patients cleared for standard induction, first doses of buprenorphine-naloxone are 2 to 4 mg, titrated over 24 hours to a clinically effective range (typically 8 to 16 mg daily, occasionally higher). For fentanyl-exposed patients, a low-dose induction may begin at 0.5 mg with gradual escalation while a full agonist is tapered — reducing precipitated-withdrawal risk at the cost of a longer runway. Comfort medications — clonidine for autonomic symptoms, loperamide for gastrointestinal distress, ondansetron for nausea, cyclobenzaprine or methocarbamol for muscle pain, hydroxyzine and trazodone for sleep — are layered throughout, not withheld until symptoms peak.

Buprenorphine, methadone, or naltrexone — choosing the MAT pathway

Three medications carry Level A evidence for opioid use disorder maintenance, and the choice matters more than any single element of the detox stay itself. Buprenorphine, a partial mu-opioid agonist with a ceiling on respiratory depression and office-based prescribing, suits most patients continuing outpatient care. Methadone, a full agonist dosed only in federally licensed opioid treatment programs, is often the correct answer for patients with long treatment histories, high tolerance, or documented non-response to buprenorphine. Extended-release naltrexone (Vivitrol), a monthly intramuscular opioid antagonist, works for clients who complete a full detox, remain opioid-free for 7 to 10 days, and prefer a non-agonist option — commonly patients with occupational testing constraints.

The decision is made collaboratively during the detox stay with the attending physician and, where appropriate, the client’s outpatient prescriber. Prior response, comorbid psychiatric medications, pregnancy status, insurance formulary, and the practical question of where continuing care will happen after discharge all feed the recommendation. No client leaves opioid detox at RECO Island without an active MAT plan, a receiving provider confirmed by phone, and a first outpatient appointment on the calendar.

Naloxone education and the safety net

The four to eight weeks after opioid detox carry the highest overdose mortality risk in the entire treatment trajectory. Tolerance drops rapidly during a medically supervised taper; return-to-use rates, even with strong aftercare, are non-trivial; and street fentanyl potency means a dose that once produced a manageable high can now be fatal. This is the single most-studied inflection point in addiction medicine outcomes research.

Every RECO Island opioid detox client receives naloxone education, a take-home intranasal naloxone prescription filled before discharge, and family training on recognizing overdose and administering the drug. Harm-reduction counseling — never use alone, fentanyl test strips, spacing after abstinence — is delivered without moralizing, because moralizing does not reduce mortality and honest instruction does. MAT continuation, particularly buprenorphine or Vivitrol maintenance, remains the single most effective mortality-reducing intervention available and is the anchor of every discharge plan.

What admission looks like from Highland Beach

Most Highland Beach admissions arrive by private vehicle down A1A or Federal Highway, a twelve-minute drive. Intake begins with a physician-conducted medical history, vital signs, urine toxicology, comprehensive metabolic panel, hepatic function testing, and CBC. Co-occurring conditions are screened with PHQ-9 for depression, GAD-7 for anxiety, and the Columbia Suicide Severity Rating Scale where indicated; ASAM Criteria’s six dimensions determine level of care. The small census — under twenty detox beds — supports nursing ratios adequate for continuous COWS reassessment and rapid physician escalation.

After acute withdrawal, transition into residential treatment happens on the same campus, without a discharge-and-readmit gap. This matters clinically: the days immediately after buprenorphine stabilization are when relapse risk is highest, and structured milieu, individual CBT with motivational-interviewing framing, group work, and psychiatric evaluation for co-occurring depression, anxiety, PTSD, or ADHD are what consolidate early recovery. Medications for co-occurring conditions — sertraline, buspirone, aripiprazole where indicated — are managed by the same psychiatric team that oversees the detox stay.

Insurance and admissions for Highland Beach residents

RECO Island is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS PPO products commonly held by South Florida residents and retirees. Benefits verification is typically complete within a business day and includes deductible status, out-of-pocket maximum, covered detox and residential day allowances, and any prior-authorization requirements specific to the plan. For clients who prefer to keep treatment off insurance for confidentiality reasons, self-pay pricing is disclosed transparently at intake.

Admissions coordinators handle prior authorization, initial documentation, and pharmacy coordination for MAT starts. For urgent situations — active withdrawal, recent overdose, imminent risk — same-day intake is standard when a bed is available. The intake line runs twenty-four hours a day; late-night arrivals are common and expected in acute-withdrawal cases.

Serving residents of: Bel Lido Isle, Boca Cove, Ocean Cove, Toscana, Penthouse.